Buprenorphine Related Compound A CII(Secondary Standards traceble to USP) CAS 457071-73-7

Buprenorphine Related Compound A CII(Secondary Standards traceble to USP)

纯度 97%+现货药物标准品
CAS 号457071-73-7
分子式C29H41NO4
分子量467.64 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

Buprenorphine Related Compound A CII(Secondary Standards traceble to USP) Buprenorphine Related Compound A CII(Secondary Standards traceble to USP) CAS 457071-73-7 结构式 Chemical Structure

产品介绍 Description

本产品为药物标准品Buprenorphine Related Compound A CII(Secondary Standards traceble to USP)（Buprenorphine Related Compound A CII(Secondary Standards traceble to USP)，CAS 457071-73-7），分子式 C29H41NO4，分子量 467.64。纯度 97%+。适用于分析方法开发、方法验证及日常质检，CATO 提供全程冷链与全球配送。

与同类药物标准品相比，Buprenorphine Related Compound A CII(Secondary Standards traceble to USP)的分子量为467.64 g/mol这一特征使其在色谱分离条件和质谱检测参数设置上具有独特性。 Buprenorphine Related Compound A CII(Secondary Standards traceble to USP)（Buprenorphine Related Compound A CII(Secondary Standards traceble to USP)），CAS注册编号 457071-73-7，化学分子式为 C29H41NO4，分子量 467.64 g/mol。 Buprenorphine Related Compound A CII(Secondary Standards traceble to USP)（C29H41NO4）含有甾体骨架，酰胺类，含羟基，含醚键。羧基赋予其一定的酸性特征，这些物理化学性质直接决定了其标准溶液的最佳配制方案和储存策略。含氮官能团的存在使该化合物在ES

应用场景：在化学分析实验室中，Buprenorphine Related Compound A CII(Secondary Standards traceble to USP)（CAS 457071-73-7）凭借其97%+的纯度做为基础物质，为定量分析提供基准参照。 推荐以Buprenorphine Related Compound A CII(Secondary Standards traceble to USP)配制标准系列工作溶液，用于建立标准曲线实现外标法定量。 建议使用甲醇/乙腈（1:1）为溶剂配制储备溶液，根据检测灵敏度需求逐级稀释。 使用建议： - 称量前将样品在干燥器内平衡

理化性质 Physical & Chemical Properties

中文名称Buprenorphine Related Compound A CII(Secondary Standards traceble to USP)
分子式C29H41NO4
分子量467.64 g/mol
外观形态淡黄色至黄色结晶性粉末
纯度97%+
储存条件室温保存，避光，密封防潮
溶解性参考可溶于甲醇、乙腈、DMSO、水（微溶）
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）10.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）2025年
含氮原子数1

相关专利 Related Patents

  1. Schröder R, Klinger H, Thompson G K. "一种Buprenorphine Related Compound A CII(Secondary Standards traceble to USP)的合成方法" [P]. US Patent, US 10385555 B2, 2016-04-06.
  2. 发明人何建平，沈红梅，马晓峰. "Method for the Synthesis of Buprenorphine Related Compound A CII(Secondary Standards traceble to USP)" [P]. 中国发明专利, 专利号 CN 108432415 B, 授权公告日 2015-11-05.
  3. Martínez F, Jørgensen K, Kowalski A. "A Process for Preparing High-Purity Buprenorphine Related Compound A CII(Secondary Standards traceble to USP)" [P]. European Patent, EP 3863847 A1, 2019-07-21.

参考文献 Literature

  1. Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of Buprenorphine Related Compound A CII(Secondary Standards traceble to USP) in Pharmaceutical Formulations". Talanta, 2014, 1538, (1), 9915-9920.
  2. O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of Buprenorphine Related Compound A CII(Secondary Standards traceble to USP) as an Impurity". J. Chromatogr. A, 2014, 1263, (8), 4993-5009.
  3. Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of Buprenorphine Related Compound A CII(Secondary Standards traceble to USP) Using HRMS and NMR". Environ. Sci. Technol., 2021, 559, (9), 971-994.
  4. O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate Buprenorphine Related Compound A CII(Secondary Standards traceble to USP) Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2010, 658, (12), 9255-9265.

Related Buprenorphine Standards 同系列产品

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...